Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.69
(
-0.96%
)
Bitcoin
74,377.41
(
0.59%
)
News Focus
News Focus

Replies to post #109570 on Biotech Values

Replies to #109570 on Biotech Values
icon url

oc631

11/28/10 8:27 PM

#109575 RE: DewDiligence #109570

Will PYMX's PMX-60056 be tested for future use reversing Rivaroxaban and Dabigatran? My impression was Portola had the upper hand going after the next generation anticoagulant reversal market.